Who
Andrew Regan
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, CDT Equity.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Sep 2025
- Last trade
- 28 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code J | —5,436,830 | filing |
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Sold | —290 | filing |
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code X | —5,436,830 at $0.00 | filing |
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code X | $5445,436,830 at $0.0001 | filing |
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code J | —5,436,830 | filing |
| 28 Aug 2026filed 2 Sep 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Sold | —290 | filing |
| 30 Jul 2026filed 2 Sep 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code J | $5445,436,830 at $0.0001 | filing |
| 30 Jul 2026filed 2 Sep 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code J | —5,436,830 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $190K100,000 at $1.90 | filing |
| 13 May 2026filed 14 May 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $190K100,000 at $1.90 | filing |
| 24 Mar 2026filed 14 May 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | —147,401 | filing |
| 24 Mar 2026filed 14 May 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code C | $15147,401 at $0.0001 | filing |
| 24 Mar 2026filed 14 May 2026 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code C | —147,401 at $0.00 | filing |
| 24 Mar 2026filed 14 May 2026 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | —147,401 | filing |
| 19 Sep 2025filed 22 Sep 2025 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $773K1,120,000 at $0.69 | filing |
News
No headline names them, or the companies they trade most, lately.